Professor Dan Peer

Prof. Dan Peer is TAU Vice President for Research and Development.

Contact Information:

Email: vpr@tauex.tau.ac.il
Phone: 6408475, 6407082 

Dan Peer is a Professor and the Director of the Laboratory of Precision NanoMedicine at Tel Aviv University (TAU). He is also the Vice President for Research and Development in Tel Aviv University. From 2017, he is the Founding and Managing Director of the SPARK program, Center for Translational Medicine at TAU.

Scientifically, Prof. Peer’s work was among the first to demonstrate systemic delivery of RNA molecules using targeted nanocarriers to the immune system and he pioneered the use of RNA interference (RNAi) as drug discovery tools in immune cells. In addition, his lab was the first to show systemic, cell specific delivery of modified mRNA in animals. This strategy has enormous implications in cancer, inflammation, and infectious diseases. His lab developed one of the largest lipid library with unique properties and strategies to immobilized natural ligands and antibodies on the surface of lipid nanoparticles (LNPs) for cell specific delivery of RNA payloads.

His lab was also the first to show systemic, high efficiency, cell specific, therapeutic genome editing in cancer. Recently, his lab also showed the first bacterial mRNA vaccine that opened new potential field of increasing the arsenal of vaccines against antibiotic resistance strains.

Prof. Peer has more than 150 pending and granted patents. More than 60% of them have been licensed to several pharmaceutical companies and biotech and his innovations have now been tested in more than 10 different clinical trials. In addition, based on his lab work, four spin-off companies were generated (one was sold in May 2021) aiming to bring innovative personalized medicine into clinical practice. He is a scientific advisory board member in more than 15 companies and on the scientific advisory board of more than 20 journals. In 2014, he was elected to the Israel Young Academy. In 2023, he was elected as an International Member to the US National Academy of Engineering. In 2024, he was elected Fellow, US National Academy of Inventors and in 2025, elected Fellow, of the Controlled Release Society. In 2025, he is also ranked “highly cited” in top 0.05% of scientists in the world in the field of RNA vaccines and therapeutics and in nanomedicine.

As Vice President for Research (VPR) and Development at TAU he oversees the recruitment of scientists in all fields, responsible for new infrastructure at the University and on the translational activities at TAU. His VPR office is also responsible for the office of awards and honors at the university submitting faculty members to international and national awards and honors.